Evidence map›Paper›PMID 37818907›Full record

ReviewJournal of surgical oncology2023

The African Research Group for Oncology: A decade fostering colorectal cancer research in Nigeria.

Anna J Dare, Samuel A Olatoke, Chukwuma E Okereke, Fatimah B Abdulkareem, Ademola Adeyeye, Olawale Badejo, Mengmeng Du, Oluwaleke J Fayenuwo, Bata M Gali, Rivka Kahn and 11 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of surgical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Anna J DareDepartment of Surgery, University of Toronto, Toronto, Ontario, Canada.
Samuel A OlatokeDepartment of Surgery, University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria.
Chukwuma E OkerekeDepartment of Surgery, Federal Medical Center, Owo, Ondo State, Nigeria.
Fatimah B AbdulkareemDepartment of Anatomic and Molecular Pathology, Faculty of Basic Medical Sciences, University of Lagos, Lagos, Nigeria.
Ademola AdeyeyeDepartment of Surgery, University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria.
Olawale BadejoDepartment of Surgery, National Hospital Abuja, Abuja, Nigeria.
Mengmeng DuDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Oluwaleke J FayenuwoAfrican Research Group for Oncology, Ile Ife, Osun State, Nigeria.
Bata M GaliDepartment of Surgery, University of Maiduguri, Maiduguri, Nigeria.
Rivka KahnGlobal Cancer Disparities Initiative, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Gregory KnappDepartment of Surgery, Division of General Surgery, Dalhousie University, Halifax, Nova Scotia, Canada.
Peter NtiamoahDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Cristina OlceseGlobal Cancer Disparities Initiative, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Mobolaji A OludaraDepartment of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos State, Nigeria.
Adeleye OmisoreDepartment of Radiology, College of Health Sciences, Obafemi Awolowo University, Ile Ife, Osun State, Nigeria.
Oluwatosin Z OmoyiolaDepartment of Morbid Anatomy, College of Health Sciences, Obafemi Awolowo University, Ile Ife, Osun State, Nigeria.
Israel A OwoadeAfrican Research Group for Oncology, Ile Ife, Osun State, Nigeria.
Murray F BrennanDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
T Peter KinghamDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.ORCID http://orcid.org/0000-0002-3359-3186
Olusegun I AlatiseDepartment of Surgery, College of Health Sciences, Obafemi Awolowo University, Ile Ife, Osun State, Nigeria.
African Research Group for Oncology (ARGO)

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

The African Research Group for Oncology (ARGO) was formed in 2013 to undertake methodologically rigorous cancer research in Nigeria, and to strengthen cancer research capacity in the country through training and mentorship of physicians, scientists, and other healthcare workers. Here, we describe how ARGO's work in colorectal cancer (CRC) has evolved over the past decade. This includes the consortium's scientific contributions to the understanding of CRC in Nigeria and globally and its research capacity-building program.

Indexed as

Colorectal NeoplasmsHealth PersonnelHumansNigeriacancer researchcolorectal cancerglobal oncologyNigeriaresearch collaborative

Identifiers

PMID37818907
PMCPMC11325740

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.